Drug intelligence / Profile preview

medium-chain triglycerides + amino acids + glucose + electrolytes

Development stage
Phase 3
Lead developer
Kelun Pharmaceutical
Modality
Small Molecules
Administration
Intravenous, Parenteral
01

Overview

Medium-chain triglycerides + amino acids + glucose + electrolytes is a ready-to-use triple-chamber parenteral nutrition (PN) injection developed by Sichuan Kelun Pharmaceutical. This combination product is designed to provide comprehensive macronutrient and electrolyte support for patients who are unable to receive adequate oral or enteral nutrition, such as those undergoing major abdominal surgery. The formulation contains a mixture of medium-chain triglycerides (MCT) and long-chain triglycerides (LCT) to provide energy and essential fatty acids, 16 amino acids for protein synthesis, glucose as a primary carbohydrate energy source, and essential electrolytes to maintain fluid and mineral balance. The triple-chamber bag technology keeps the lipid emulsion, amino acids, and glucose solutions separate until administration, which enhances stability and reduces the risk of contamination compared to hospital-compounded all-in-one mixtures. Its primary therapeutic goal is systemic nutritional repletion by delivering energy substrates and nitrogen directly into the bloodstream.

Brand names
Nutriflex LipidKe Lun Ning
Other names
MCT/LCT Fat Emulsion, Amino Acids (16), Glucose (16%) and Electrolytes InjectionMCT/LCT Fat Emulsion, Amino Acids (16), Glucose (30%) and Electrolytes InjectionTriple-chamber parenteral nutrition injection

Beyond the preview

Go deeper on medium-chain triglycerides + amino acids + glucose + electrolytes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on medium-chain triglycerides + amino acids + glucose + electrolytes.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call